Bezlotoxumab as Treatment for Recurrent/Chronic <i>Clostridioides difficile</i> Infection in Pediatric Stem Cell Transplant Recipients: A Multi‐Institutional Experience
Aaron E. Fan(The University of Texas MD Anderson Cancer Center), Irtiza Sheikh(The University of Texas MD Anderson Cancer Center), Priti Tewari(The University of Texas MD Anderson Cancer Center), Sajad Khazal(The University of Texas MD Anderson Cancer Center), Kris M. Mahadeo(Duke University), Shaikha Alqahtani(Duke University), Demetrios Petropoulos(The University of Texas MD Anderson Cancer Center), Natalie Dailey Garnes(National Institutes of Health)
Cited by 0
Related Papers
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
|New England Journal of Medicine|2006|902
Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy
|Nature Reviews Clinical Oncology|2018|237
A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease
|Transplantation and Cellular Therapy|2020|201
A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant
|Blood Advances|2020|93
Invasive Mechanical Ventilation and Mortality in Pediatric Hematopoietic Stem Cell Transplantation
|Pediatric Critical Care Medicine|2016|88